levodopa has been researched along with sch 23390 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, GZ; Mo, J; Sun, PH; Yu, LP; Zhang, H; Zhen, X | 1 |
| Cenci, MA; Lindgren, HS; Ohlin, KE | 1 |
| Beeler, JA; Cao, ZF; Ding, Y; Kang, UJ; Kheirbek, MA; Koranda, J; Murakami, M; Zhuang, X | 1 |
| Bido, S; Cenci, MA; Marti, M; Mela, F; Morari, M | 1 |
| Adlard, PA; Ayton, S; Bush, AI; Cherny, RA; Finkelstein, DI; George, JL | 1 |
| Björklund, A; Carta, M; Fidalgo, C; Lisci, C; Shin, E; Stancampiano, R; Tronci, E | 1 |
| Bagetta, V; Branchi, I; Calabresi, P; Ghiglieri, V; Latagliata, EC; Morelli, E; Pascucci, T; Pendolino, V; Picconi, B; Poggini, S; Puglisi-Allegra, S; Sgobio, C | 1 |
| Antinori, S; Devoto, P; Fattore, L; Fratta, W; Frau, R; Gessa, GL; Saba, P | 1 |
| Cruz, AV; Delaville, C; Gerber, CM; McCoy, AJ; Walters, JR | 1 |
| Chammas, C; Soghomonian, JJ; Zhang, K | 1 |
| Fan, X; Harrast, P; Heinzer, AK; Hess, EJ; Jinnah, HA; Pare, JF; Raike, RS; Rose, SJ; Smith, Y; Thompson, VB; Weinshenker, D; Yu, XY | 1 |
| Babapour, V; Hashemzadeh, M; Panahi, N; Zendehdel, M | 1 |
| Ashby, R; Karouta, C; Morgan, I; Thomson, K | 1 |
| Feng, J; Gao, S; Liu, J; Liu, W; Sun, Y; Wang, Y; Yao, L; Zhang, G; Zhang, Q; Zhou, Y | 1 |
14 other study(ies) available for levodopa and sch 23390
| Article | Year |
|---|---|
L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antiparkinson Agents; Antipsychotic Agents; Benzazepines; Berberine; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Disease Models, Animal; Dopamine Agents; Drug Administration Schedule; Drug Interactions; Dyskinesias; Gene Expression Regulation; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; RNA, Messenger; Serotonin Receptor Agonists; Transfection; Tritium | 2010 |
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2009 |
Dopamine-dependent motor learning: insight into levodopa's long-duration response.
Topics: Animals; Behavior, Animal; Benzazepines; Dopamine; Dopamine Agents; Homeodomain Proteins; Learning; Levodopa; Mice; Mice, Knockout; Motor Skills; Movement Disorders; Reaction Time; Rotarod Performance Test; Time Factors; Transcription Factors | 2010 |
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
Topics: Animals; Benzazepines; Corpus Striatum; Dopamine Antagonists; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Glutamic Acid; Levodopa; Male; Microdialysis; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra | 2012 |
The effect of dopamine on MPTP-induced rotarod disability.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzazepines; Dopamine; Dopamine Agents; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Parkinsonian Disorders; Receptors, Dopamine D1; Rotarod Performance Test; Time Factors | 2013 |
The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.
Topics: Amphetamine; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Benzazepines; Buspirone; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Mesencephalon; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Serotonin Receptor Agonists | 2014 |
l-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via β-adrenergic receptors.
Topics: Animals; Antiparkinson Agents; Benzazepines; Dentate Gyrus; Disease Models, Animal; Dopamine; Dopamine Antagonists; Electric Stimulation; Functional Laterality; Levodopa; Long-Term Synaptic Depression; Male; Microdialysis; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Sulpiride | 2014 |
Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation.
Topics: Animals; Behavior, Animal; Benzazepines; Cocaine; Disulfiram; Dopamine; Dopamine Agents; Dopamine beta-Hydroxylase; Dopamine Uptake Inhibitors; Drug-Seeking Behavior; Extinction, Psychological; Imidazoles; Levodopa; Male; Microdialysis; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Self Administration; Thiones | 2016 |
Subthalamic nucleus activity in the awake hemiparkinsonian rat: relationships with motor and cognitive networks.
Topics: Action Potentials; Adrenergic Agents; Animals; Antiparkinson Agents; Benzazepines; Cognition Disorders; Disease Models, Animal; Dopamine Antagonists; Evoked Potentials; Functional Laterality; Levodopa; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Long-Evans; Subthalamic Nucleus; Time Factors; Tyrosine 3-Monooxygenase; Wakefulness | 2015 |
Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice.
Topics: Animals; Antiparkinson Agents; Benzazepines; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Glutamate Decarboxylase; Levodopa; Medial Forebrain Bundle; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Oxidopamine; Parkinson Disease; Psychomotor Performance; Receptors, Dopamine D1; Receptors, G-Protein-Coupled | 2015 |
A new knock-in mouse model of l-DOPA-responsive dystonia.
Topics: Animals; Benzazepines; Brain; Catecholamines; Disease Models, Animal; Dopamine Agents; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dystonia; Humans; Levodopa; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation; Radionuclide Imaging; Stereotyped Behavior; Tritium; Tyrosine 3-Monooxygenase | 2015 |
Interaction between central GABAA receptor and dopaminergic system on food intake in neonatal chicks: role of D
Topics: Adrenergic Agents; Analysis of Variance; Animals; Animals, Newborn; Benzazepines; Chickens; Dopamine; Dopamine Agents; Eating; Female; Food Deprivation; GABA Agents; gamma-Aminobutyric Acid; Injections, Intraventricular; Isoxazoles; Levodopa; Oxidopamine; Receptors, Dopamine D1; Receptors, GABA-A | 2018 |
Levodopa inhibits the development of lens-induced myopia in chicks.
Topics: Animals; Benzazepines; Chickens; Disease Models, Animal; Dose-Response Relationship, Drug; Intravitreal Injections; Lenses; Levodopa; Male; Myopia; Ophthalmic Solutions; Receptors, Dopamine D2; Spiperone | 2020 |
Inhibition of striatal dopamine D
Topics: Animals; Benzazepines; Dopamine; Dopamine Antagonists; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats, Sprague-Dawley; Receptors, Dopamine D5 | 2021 |